Appili Therapeutics Inc
APLI
Company Profile
Business description
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Contact
1344 Summer Street
Suite 21
HalifaxNSB3H 0A8
CANT: +1 902 442-4655
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
9
Stocks News & Analysis
stocks
Moated ASX player makes moves to support growth in China
a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.
stocks
Cochlear earnings: Shares overvalued as demand softens
Cochlear’s met expectations, but investors overly optimistic.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,170.00 | 63.50 | -0.69% |
| CAC 40 | 7,884.05 | 39.40 | -0.50% |
| DAX 40 | 24,314.77 | 44.53 | -0.18% |
| Dow JONES (US) | 44,911.82 | 34.30 | -0.08% |
| FTSE 100 | 9,157.74 | 18.84 | 0.21% |
| HKSE | 25,219.39 | 42.54 | 0.17% |
| NASDAQ | 21,629.77 | 6.80 | 0.03% |
| Nikkei 225 | 43,625.92 | 88.39 | -0.20% |
| NZX 50 Index | 12,928.68 | 41.96 | -0.32% |
| S&P 500 | 6,449.15 | 0.65 | -0.01% |
| S&P/ASX 200 | 8,892.70 | 66.60 | -0.74% |
| SSE Composite Index | 3,742.57 | 14.55 | 0.39% |